SYNTHETIC BLOOD 10-K

Company

TENAX THERAPEUTICS, INC.

Filed

July 26, 2001

Period of Report

April 30, 2001

Accession Number

0001013176-01-500111

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →